Sugi Predict

Sugi Predict / Compounds / SCHEMBL20764456

SCHEMBL20764456

SCHEMBL20764456

CC(NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)C(N)CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(N)=O)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ TFPI P10646 1/20 0.57
▸ OPRL1 P41146 3/20 0.53
▸ BACE1 P56817 2/20 0.52
▸ PTPN1 P18031 1/20 0.50
▸ NMUR2 Q9GZQ4 1/20 0.50
▸ NMUR1 Q9HB89 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20764468 0.94 TFPI (0.56) TFPIOPRL1BACE1
SCHEMBL23273225 0.94 TFPI (0.54) TFPIOPRL1BACE1
SCHEMBL30421823 0.93 TFPI (0.61) TFPIBACE1
SCHEMBL29622911 0.91 TFPI (0.62) TFPIOPRL1BACE1
SCHEMBL29417385 0.90 PTH1R (0.54) TFPI
SCHEMBL29679886 0.90 NPY5R (0.56) TFPI
SCHEMBL30435346 0.89 TFPI (0.66) TFPIOPRL1
SCHEMBL30642059 0.89 TFPI (0.66) TFPIOPRL1
SCHEMBL31031553 0.89 TFPI (0.63) TFPIOPRL1BACE1
SCHEMBL30799806 0.89 BACE1 (0.54) BACE1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3672626-A1 COMPOSITION OF TUMOR-ASSOCIATED PROLIFERATIVE PEPTIDES AND RELATED ANTI-CANCER IMMUNOGEN FOR THE TREATMENT OF LUNG CANCERS AND OTHER CANCERS Onkologix Ltd (US) 2020-07-01 — — EP disclosed
WO-2019038671-A1 COMPOSITION OF TUMOR-ASSOCIATED PROLIFERATIVE PEPTIDES AND RELATED ANTI-CANCER IMMUNOGEN FOR THE TREATMENT OF LUNG CANCERS AND OTHER CANCERS ONKOLOGIX LTD (US) 2019-02-28 — — WO disclosed
Send feedback